Overview and Practical Implementation Guidelines
Executive Overview & Regulatory Pathway on SFDA GHAD
Securing an official Product Classification (تصنيف المنتج) from the Saudi Food and Drug Authority (SFDA) is the foundational regulatory milestone governing dietary supplements, wellness formulations, and herbal preparations before commercial manufacturing or import clearance. Rather than applying a blanket standard, SFDA enforces stringent scientific boundaries that segregate products into Food Supplements, Health/Herbal Products, or Pharmaceutical Drugs (OTC) based on active ingredient concentrations, upper tolerable nutrient intake limits (UL), herbal safety monographs, and stated marketing claims.
To classify your product accurately in the most efficient regulatory stream without risking costly rejections, leverage GNSCO Supplement Classification & Registration Services for expert dossier preparation and GHAD portal administration.
Core Strategic Pillars of SFDA Product Classification
- Upper Tolerable Intake Limits (UL): Exceeding daily micronutrient thresholds established in Saudi regulations instantly reclassifies a supplement into a pharmaceutical drug requiring clinical dossiers and pharmaceutical manufacturing licenses.
- Botanical Monograph Scrutiny: Herbal extracts and botanical ingredients are evaluated against SFDA restricted lists; unauthorized or toxic herbs trigger immediate file rejection.
- Marketing Claim Strictness: Formulations claiming to cure, treat, or prevent pathological disease states are legally classified as medicinal pharmaceuticals.
- Institutional GHAD Account: Formal classification applications must be routed exclusively through an authenticated corporate entity account on the SFDA GHAD digital portal.
1. Regulatory Classification Matrix: Food Supplement vs Health Product vs Drug
The following comparative matrix outlines the statutory boundaries applied by the SFDA Product Classification Department:
| Classification Parameter | Food Supplement | Health / Herbal Product | Pharmaceutical Drug (OTC) |
|---|---|---|---|
| Active Ingredients | Vitamins, minerals, amino acids, common safe botanical extracts. | Standardized herbal extracts, traditional medicinal oils, pharmacopoeial herbs. | Purified Active Pharmaceutical Ingredients (API) with potent biological activity. |
| Dosage Limits | Nutritional supplemental doses below Upper Tolerable Limits (UL). | Targeted therapeutic dosages with documented mild therapeutic index. | High therapeutic dosages aimed at altering physiological functions. |
| Permitted Claims | General structure/function claims (e.g. supports bone health, aids immunity). | Symptomatic relief claims (e.g. temporarily eases cough, supports digestion). | Treatment, cure, diagnosis, or prevention of chronic/acute diseases. |
| Facility Standards | HACCP / ISO 22000 certified food manufacturing plants. | Certified current Good Manufacturing Practice (cGMP) facilities. | PIC/S certified pharmaceutical manufacturing facilities with cleanroom controls. |
| Review Timeline | 30 to 60 business days within the Food Sector. | 60 to 120 business days within Health Products Sector. | 6 to 12 months requiring full Common Technical Dossiers (CTD). |
Evaluate your product's preliminary classification instantly using our Interactive Supplement Registration Readiness Calculator to clarify your registration dossier requirements.
2. Technical Submission Requirements on the GHAD Portal
To ensure seamless processing without technical queries or rejections, compile the following foundational dossier items:
- Comprehensive Master Formulation: Disclose 100% of active and inactive excipients with quantitative metric values per serving and percentage of daily value (%DV).
- Standardized Botanical Nomenclature: Provide the exact Latin binomial name (Genus, Species, Variety), plant part utilized (leaf, root, bark), and extraction ratio.
- Bilingual Artwork Mockups: Submit high-resolution flat packaging art showing complete Arabic and English nutritional panels, suggested usage, and mandatory warnings.
- Certificate of Free Sale or Manufacturing License: Evidence confirming lawful commercial sale in the country of origin or local cGMP licensing via GNSCO Contract Manufacturing Partnerships.
Regulatory Reality Check: International Approvals Do Not Guarantee SFDA Acceptance
Holding dietary supplement status with the US FDA or European EFSA does not automatically ensure equivalent classification in Saudi Arabia. The SFDA enforces distinct Gulf and national standards that frequently classify US/EU supplements as regulated health or pharmaceutical products.
3. Post-Classification Roadmap & Product Listing
Once the official classification letter is issued, it determines your exact regulatory trajectory:
- Food Supplement Designation: Proceed immediately with digital product listing on the SFDA Food Sector portal and settle the statutory registration fees.
- Health Product Designation: Assemble stability testing reports, batch manufacturing records, and cGMP proofs for evaluation by the Health Products Directorate.
- Archiving the Classification Letter: Retain the stamped classification document as a mandatory component for customs clearance under the FASAH trade platform.
Need to apply this to your facility?
Share the activity, city and current stage, and we can help define an appropriate work scope.
Explore supplement development services